ArticleFrontiers in oncology2021

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma.

Shuai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.